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INTRODUCTION 
 Eye is a mirror that reflects pathological changes occurring in many 
organs of the body. Numerous systemic disorders affect both eye and kidney. 
Examination of eye is an in dispensable part of the clinical assessment of a 
patient with renal disorders.  
 CRF is irreversible and progressive process that result in END 
STAGE RENAL DISEASE(ESRD) where patient has to depend on renal 
replacement for survival.1 
 Richard bright in 1836 first associated renal disease with blindness.2  
By ESRD 80% of pts will have secondary hypertension.3 Ocular morbidity 
may be  due to coexisting risk factors like hypertension, diabetes, uremia and 
anemia. The ophthalmologist may be consulted for a variety of reasons about 
the patients whose problem appear renal.  
 On the other hand nephrologists may be aware of many ocular 
manifestations of renal disorders which are common and rare in nephrology 
and the potential toxicity of therapeutic agents.  
 Inflammatory reactions of conjunctiva and episclera can be associated 
with sudden marked raise in serum calcium.4 - 5 Conjunctival degenerative 
changes (e.g) pinguecula are frequently seen in CRF.6    
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 Diabetes is the most common disorder with ocular and renal 
manifestations.7 Rubeosis iridis and neovascular glaucoma occur due to 
posterior segment pathology. Rising concentration of intracellular calcium 
might contribute to early cataractegenesis and calcium deposit in lens.8 
 Hypertension affects the eye and kidney in parallel and very often 
occurs along with diabetes.  
 Hypertensive changes are particularly  severe in renal failure. This has 
been attributed to the effects of retained nitrogenous products.9 Accelerated 
Hypertension can result in optic disc edema.10 
 Renal disease and ocular complications in diabetes are frequently 
disturbing and destined to become one of the challenging problems of the 
future.  
 Blindness due to proliferative retinopathy or maculopathy is 
approximately 5 times in diabetic patients with nephropathy compared with 
non albuminuric patients.11In India majority of end stage renal disease 
patients are of type II diabetes . 5% of diabetic patients die of end stage renal 
disease.  
Diabetic retinopathy (DR) tends to deteriorate with falling renal 
function and poorly controlled blood pressure.12 Diabetic Microangiopathy 
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has been recognized as a major cause of kidney involvement in diabetes. 
Diabetic nephropathy ultimately leads to end stage renal disease.  
Both anterior and posterior optic neuropathy can occur in CRF, when 
hemoglobin level falls below 5gm% retinopathic features like retinal 
hemorrhages, hard and soft exudates and pallor of optic discs could be 
present .The retinal arterioles look pale and veins appear distended.  
Retinopathy is often asymptomatic in its most treatable stage. Delay in 
diagnosis can result in significant increase in patients risk of visual loss. 
Type II DM accounts for 90% - 95% diabetes cases and differs from type I 
diabetes in average age of onset and Etiology. 13 
Patients with type I diabetes, who are generally younger and are more 
likely to live long enough to benefit from tight glycemic control, than 
patients with type II disease, who face a shorter life expectancy, because of 
their age and risk of cardiovascular disease.14 For patients with co-existent 
disease, the delayed benefits of glycemic control may be offset by the more 
immediate inconvenience, complications, and costs of intensive treatment 
and by the health effects of co morbid conditions. Ocular condition is also an 
indicator of metabolic control of the disease process.  
Similarly an unknown case of chronic renal failure with its ocular 
complications, may first present to an ophthalmologist. This study is an 
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attempt to access the ocular status, complications associated with CRF. It is 
intended to highlight the importance of ocular examination, to screen 
patients for any potential visual threat, so that necessary treatment or advice 
can be given, before they become irreversibly visually impaired.  
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AIMS AND OBJECTIVES  
a. To record the stage of retinopathy in end stage renal disease patients 
    of diabetic origin and on treatment. 
b. To record the progress of retinopathy at end of 6months and      
     12months in these patients.  
c.  To correlate the severity of retinopathy with renal failure.  
d.  To know associated findings with patients with diabetic retinopathy     
  and diabetic nephropathy. 
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DIABETES – RENAL FAILURE – EYE  
 Diabetes is defined as a major group of metabolic disease 
characterized by hyperglycemia, with disturbances in carbohydrate, fat and 
protein metabolism either due to defect in insulin secretion, action or both.15 
It is the chronic hyperglycemia that causes most of the microvascular 
damage and contributes to the development of macrovascular disease.  
 In type I diabetes onset is symptomatic and after ten years seventy 
percent of the patients have retinal abnormalities and after twenty years 30-
40% have clinical nephropathy. In type II diabetes the intial onset is 
asymptomatic and 15-20% have retinal abnormalities and 5-10% have 
sustained microalbuminurea at the time of diagnosis.16 
  MICROVASCULAR COMPLICATIONS   
Nephropathy    Retinopathy  
    Neuropathy  
Macrovascular Complications   
 Accelerated and premature atherosclerosis involving cornea, 
cardiovascular and renal systems.  
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KIMMELSTIEL – WILSON LESIONS 
 
PATHOLOGY PICTURE - 1 
 
PATHOLOGY PICTURE - 2 
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Diabetic Nephropathy  
 The most frequent cause of renal involvement in disease affecting 
other organs is diabetes. Renal failure in those with Insulin dependent 
diabetes mellitus and disease duration of 5 years together with hypertension 
and retinopathy is highly suspicious of diabetic nephropathy.  
 In Non Insulin dependent diabetes renal involvement seems to 
occur as frequent as individuals with insulin dependent diabetes after the 
same duration of disease but in this age group other renal disease are 
common.  
The kidney may be damaged in three ways16  
1. Glomerular damage  
2. Ascending infections  
3. Ischemia due to hypertrophy of afferent and efferent 
arterioles.  
DIABETIC GLOMERULAR SCLEROSIS  
 Clinical nephropathy secondary to glomerular damage usually 
manifests 15-25 years after the diagnosis and affects (30-40%) of the 
patients diagonised under the age of 30years.  
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 It is the leading cause of premature death in young diabetic 
patients. Older diabetics develop nephropathy but the proportion affective is 
much smaller. The intial structural lesion in the glomerulus is thickening of 
the basement membrane. Associated changes may result in disruption of 
protein cross linkages that make the membrane an effective filter. In 
consequence a progressive leak of protein into the urine occurs.  
 The earliest evidence of this is microalbuminuria which in turn in 
some years progressed to intermittent albuminuria followed by persistent 
proteinuria. Once overt proteinuria occurs renal function invariably declines 
with 50%  of the people reaching end stage renal disease with in 7 years of 
onset of proteinuria.  
CHRONIC RENAL FAILURE  
 CRF is defined as permanent and significant reduction in 
glomerular filteration rate. In nearly all patients once GFR is reduced to 1/3rd 
of normal (below 30-40ml), Serum creatinine more than 8mg /1dl 
progressive renal failure develops and eventually leads to but often slowly 
and over the years to ureamic syndrome and end stage renal disease. 
Uraemia can be defined as sign’s and symptoms associated with retention of 
end products of protein metabolism. The ureamic syndrome is quite variable 
and unpredictable in the time of onset during the course of renal failure 
16 
 
 More commonly it occurs at blood urea nitrogen level of more than 
100mg / dl and serum creatinine level of more than 10mg/ dl. It is good 
medical practice to initiate replacement theraphy just before the onset of 
ureamic symptoms usually when GFR is 5-10ml/ dl minute.  
END-STAGE RENAL DISEASE  
 ESRD is final common end despite the dissappearance of renal 
insult that initially lead to the loss of some nephrons. It is striking that 60% 
of ESRD is now due to diabetes and essential hypertension. The most 
common primary renal cause of failure is glomerulo nephritis.  
MANAGEMENT  
 The under lying cause of renal disease should be treated 
aggressively wherever possible eg. Tight diabetic control.  
The Guideline of treatment are :  
- Blood pressure control  
- Treatment of hyperkalemia  
- Correction of acidosis  
- Regular treatment of hypocalcemia and hyperphosphatemia.  
- Dietry protein restriction  
17 
 
- Fluid restriction along with salt.  
- Treatment of hyperlipedemia  
- Correction of aneamia  
- Patient education  
RENAL REPLACEMENT THERAPY  
- Haemodialysis  
- Haemofiltration  
- Haemodiafiltration  
- Peritoneal  dialysis  
- Kidney transplantation  
 When no contraindication exists,  all patients received renal 
replacement therapy. Initially patients with ESRD are managed by 
conservative therapy but eventually they required haemodialysis, Peritoneal  
dialysis or transplantation. Because of limited success of each of these 
modalities ESRD  should be approached with the concept of moving from 
one form of therapy to another.  
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DIALYSIS IN ESRD OF DIABETES MELLITUS  
  No distinction is attempted in ESRD treatment outcome between 
type I and type II diabetes mellitus patients. Today it is generally accepted 
that the renal replacement therapy should be considered earlier in diabetic 
than non-diabetic ureamic patients.  
 Except in severe macroangiopathy, renal transplantation should be  
the  first objective. Today an increasing proportion of patients who are 
accepted for the renal replacement therapy have diabetes and suffer from 
retinopathy. It is therefore essential that the nephrologist  is familiar with the 
principles of treatment and major complications of the disease particularly 
retinopathy, diabetic foot and cardiac problems which  are the main causes of 
morbidity and mortality.  
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CLASSIFICATION OF DIABETIC RETINOPATHY 
- Duke – Elder  
- Airlic – House  
 This system proposes fundus photography, flourescein 
angiography, ophthalmoscopy, fundus diagrams and slit lamp biomicroscopy 
of the retina.  
- Kanski Classification   
 This is the popular and widely accepted classification of diabetic 
retinopathy. It is basically treatment oriented ophthalmoscopic classification.  
- Modern ETDRS Classification17,18   
 The early treatment diabetic retinopathy study has developed 
systems to grade the severity of diabetic retinopathy at various stages by 
assessing the lesions seen through stereoscopic colour fundus photographs 
and fluorescein angiograms.  
NON-PROLIFERATIVE DIABETIC RETINOPATHY  
A.MILD NPDR  
 At least one microaneurysm. Definition not met with B, C, D, E, 
and F.  
20 
 
DIABETIC RETINOPATHY DISEASE SEVERITY SCALE 
 
Mild NPDR 
 
Microaneurysms only 
 
Moderate NPDR 
 
More than just Microaneurysms but 
less than severe nonproliferative 
diabetic retinopathy  
Sereve NPDR 
 
Any of the following  
 20 intraretinal hemorrhages in 
each of 4 quadradants OR 
 Definite venus beading in 2+ 
quadrants OR 
 Prominent IRMA in 1+ quadrant 
and no PDR  
 
Proliferative DR (PDR)  
 
1 or more of  
 Neovascularization  
 Vitreous/ preretinal 
hemorrhage  
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B. MODERATE NPDR 
 Hemorrhages and/or microaneurysm- standard photograph 2A and 
/ or soft exudates, venous beading or IRMAs definitely present. Definitions 
not met with C, D, E and F.  
C. Severe NPDR  
  Hemorrhages and/or microaneurysms in all four quadrants. Venous 
beading in two or more quadrants. IRMA>Standard photograph # 8A in 
atleast one quadrant.  
D. Very Severe NPDR  
   Any two or of C.  
  Definition not met with E,F.  
PROLIFERATIVE DIABETIC RETINOPATHY   
 E. EARLY PDR  
  New vessels.  
 F. HIGH RISK PDR  
  NVD 1/3- ½ disc area or  
  NVD & Viterous/preretinal   
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4‐2‐1 Rule 
 
4 quadrants H/MA ( STD 2A)  
 
4 quadrants VB 
 
1 quadrant IRMA ( STD 8A)  
Any of these situations – SEVERE NPDR 
23 
 
  NVE – ½ disc area and preretinal/vitreous hemorrhage  
In retina, the primary sources VEGF – A are ganglion cells. Muller and 
colleagues have shown that the level of VEGF (A) –in ocular tissues 
correlates with new vessel formation 19.  
PROLIFERATIVE DIABETIC RETINOPATHY    
  The exact pathogenesis of retinal neovascularization remains 
unclear. In 1948, observations led Michelsen to propose that there exists in 
the retina a risk factor or factors affecting the budding of new vessals. Later 
it was explained by Ashton and others that hypoxia was the primary stimulus 
for production of angiogenic factors.  
  The most frequently studied molecules include basic fibroblast 
growth factor (bfgf), vascular endothelial growth factor (VEGF) growth 
hormone, and more recently the angiopoietiens studies however indicate 
VEGF as the main predictor of angiogenesis.20,32,33 
EPIDEMIOLOGY OF DIABETIC RETINOPATHY   
  The Wisconsin Epidemiologic15,30 study of diabetic retinopathy 
was a large population based study on subjects with diabetes with younger 
onset and those diabetics after 30 years. Few important results were,  
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NEO VASCULARISATION AT DISC (NVD) 
 
NEO VASCULARISATION ELSEWHERE (NVE) 
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- Severity of retinopathy was related to the duration of 
diabetes ranging from 2% in subjects with diabetes for less 
than 2yrs to 98percent in subjects with diabetes for 15yrs or 
more32. The severity also increased  with duration of 
diabetes.  
- In contrast the older onset was likely to have retinopathy at 
the time diabetes was diagnosed.  
  The study also found out that elevated glycoslylated hemoglobin 
was associated with severe retinopathy in all age groups. Proterniuria was 
associated with severe retinopathy in both groups.  
PROLIFERATIVE DIABETIC RETINOPATHY    
  NVD  
  Neovascularization is frequently found within 45degrees of the 
optic disc. It is observed at the disc as a cart wheel configuration radiating 
from the center best indentified by stereoscopic view, by either contact or 
precorneal lenses or stereoscopic photography.  
NVE  
  All other neovscularization other than from disc is called NVE. it 
occurs typically adjacent to areas of capillary closure, marked by cotton 
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wool spots and hemorrhagic microaneurysms. IRMA may be difficult to 
differentiate from early NVE. Flourescein angiography shows leakage in 
new vessels as a differentiating feature.  
VITREOUS AND PRERETINAL HEMORRHAGE   
  Small hemorrhages may occur near growing tips of the vessel but 
they are usually subhyaloid. Progression of vitreous detachment starts on 
either side of vascular arcades of fovea. Vitreous usually remains attached to 
the disc by proliferating fibrovascular tissue. Vitreous hemorrhage may 
occur as a result of vitreous traction on new vessels.  
VITREOUS TRACTION AND FIBROUS PROLIFERATION   
  Fibrous tissue develops along the vessels which may subsequently 
contract. Contraction of posterior vitreous face and fibrovascular 
proliferation leads to tractional retinal detachment. Retina along the temporal 
arcades is the first to detach and extends to involve the fovea. Contraction of 
fibrovascular tissue can also lead to distortion or horizontal displacement of 
macula.  
RUBEOSIS   
  Iris neovascularization in diabetes is observed in proliferation 
changes and also in long standing changes of diabetic retinal detachment.  
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HYPERTENSIVE RETINOPATHY 
 
CLINICALLY SIGNIFICANT MACULAR EDEMA 
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DIABETIC MACULOPATHY   
  Diabetic macular edema may be present at any level of retinopathy 
and alters the structure of macula in any of these manners.21  
 Macular edema, i.e., a collection of intraretinal fluid in the macula  
  with or without lipid exudates and with or without cystoid changes  
 Non perfusion of parafoveal capillaries with or without intraretinal fluid  
 Traction in the macula by fibrous tissue proliferation causing surface  
 wrinkling or macular detachment 
 Intraretinal or preretinal hemorrhage in the macula  
 Lamellar or full thickness retinal hole formation  
 Any combination of the preceding.  
CSME as defined by ETDRS includes any of these  
 Retinal thickening at or within 500microns of the center of macula 
 Hard exudate at or within 500microns of the center of the macula,  
 if there is the thickening of the adjacent retina  
 Any are of retinal thickening at least one disc area in size at least  
 part of which is within 1 disc diameter of the center of the macula.  
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REVIEW OF LITERATURE   
OCULAR COMPLICATIONS OF RENAL FAILURE   
  The association of blindness and end stage renal disease was first 
noted by Bright and fundus changes in uraemic patients was described by 
Leibrich.21,22,23 Subsequently this was named Bright disease or albuminuric 
retinitis. By the end of the nineteeth century and as a result of hypertensive 
changes, albuminuric was no longer consider as a separate entity, but as 
manifestation of hypertension in uraemic patients.  
  Since the introduction of effective anti hypertensive treatment, dialysis 
and kidney transplantation such patients with severe hypertension have 
become rare. Never the less hypertension is still an important problem in 
kidney diseases and complications of atherosclerosis is common in renal 
patients as a result of chronic hypertension and hyperlipidaemia.  
VASCULAR LESIONS  
  Arterial hypertension is a frequent complication of a congenital and 
acquired renal and renovascular disorders. Arteriolar narrowing, tortuosity 
occur in patients with severe hypertension and ischemic changes may occur 
in retina, choroids and optic nerve producing cotton wool spots, hard 
exudates, exudative detachments, disc edema and optic atrophy.  
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BLINDNESS  
  In patients with severe and long standing hypertension a severe 
reduction in arterial pressure may cause infarction of optic nerve followed by 
blindness or visual loss. In occasional patients with  cerebrocortical 
infarction occurs under these circumstances with cerebral blindness. Anterior 
ischemic optic neuropathy and retinal infarction have been described as 
complication of haemodialysis associated with hypotension. Uraemia, 
anemia and disc edema due to intracranial hypertension are other risk factors 
for optic neuropathy in patients with renal disease. In addition patients with 
chronic hypertension are predisposed to retinal arterial and venous 
obstructive disease leading to visual loss. Sudden blindness like purtschners 
like retinopathy with or without cotton wool spots may occur in patients in 
chronic renal failure with or without trauma, pancreatitis or autoimmune 
disease. The precipitating factors for this retinovaso-occlusive disorder 
remain unclear. The conditions have been described in renal transplant also.  
SEROUS RETINAL DETACHMENT AND 
CORTICOSTEROID INDUCED CHANGES IN RETINAL 
PIGMENT EPITHELIUM  
  Serous retinal detachment and diffuse retinal pigment epitheliopathy 
or chronic central serous chorioretinopathy may follow organ 
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transplantation, haemodialysis or patients receiving steroid therapy. In severe 
forms bilateral bullous retinal detachment, multiple retinal pigment epithelial 
detachments and yellow fibrin like subneural exudates beneath the sensory 
retinal detachment may be observed.  
  Flourescein angiography shows wide spread retinal pigment epithelial 
changes and leakage’s. Several factors may play a role in precipitating 
serous detachment in patients with renal failure, including impaired fluid and 
electrolyte imbalance, choroidopathy associated with hypertension, 
thrombotic microangiopathy or immune complex vasculitiditis and 
dysfunction of overlying epithelium which may be associated with renal 
disease such as membranoproliferative glomerulonephritis type 2. 
Corticosteroid can damage the RPE and predispose a patient to serous retinal 
detachment. Where as stress may produce chronic serous retinopathy. The 
visual prognosis is unfavourable. A decrease of corticosteroid dosage may 
help in reducing visual symptoms and enhance resolution of retinal 
detachment. In refractory cases focal laser photocoagulation may be applied 
to leakage points.  
GLAUCOMA  
  Intraocular pressure may increase during haemodialysis and cause 
acute angle closure glaucoma in predisposed patients with increased 
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resistance to aqueous outflow. The increase in pressure is thought to be part 
of cerebral edema that occurs as a consequence of the rapid reduction in 
serum osmolality. Corticosteroid is another risk factor for an increased 
intraocular pressure. In patients who are beginning long term haemodialysis 
or corticosteroids intraocular pressure should be measured early as diagnosis 
and treatment of glaucoma may prevent visual loss.  
CORNEAL CALCIFICATION IN RENAL FAILURE    
  In patients with renal failure and associated hyperparathyroidism soft 
tissue calcification are first detected first in the peripheral interpalpebral 
cornea and adjacent conjunctiva. The corneal calcification eventually spread 
to toward visual axis in patients on chronic intermittent haemodialysis 
producing band keratopathy with decrease in visual acuity epithelial erosions 
resulting in severe pain. Patients with renal failure and hypercalcemia may 
present with inflamed pingecula and diffuse inflammatory edema.  
BROWN TUMORS OF THE ORBIT  
  Brown tumors of  the orbit are observed with the renal failure and 
secondary hyperparathyroidism. Brown tumors are focal bony lesions 
composed of giant cell masses and extravasation of blood affecting patients 
with primary or secondary hyperparathyroidism.  
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DIABETIC RETINOPATHY AND RENAL FAILURE  
  Nephropathy and retinopathy are the major microvascular 
complications of diabetes.22,23 It is the chronic hyperglycemia that cause 
most of the microvascular damage and contributes to the development of the 
macrovascular disease. This microangiopathy affects nearly all diabetics and 
while most diabetics and while most diabetics may develop clinically evident 
retinopathy, nephropathy occurs in a subset.  
  In patients with nephropathy retinopathy is always present and 
proliferative retinopathy is common. However thirty five percent of the 
patients with proliferative retinopathy have no signs of diabetic nephropathy 
and these patients will probably never develop diabetic nephropathy.  
  Retinopathy tends to deteoriate as renal failure develops in patients 
with poorly controlled blood pressure and in patients in whom no treatment 
has been given. In WESDR study proteinuria was strongly associated with 
diabetic retinopathy. Older onset diabetes with proteinuria were also more 
likely to have proliferative retinopathy. Renal retinopathy will overlie 
diabetic retinopathy and consist of a hypertensive component and a ureamic 
component. The hypertensive changes include nerve fibre layer infarcts, 
cotton wool spots and arterio-venous changes. The Ureamic changes include 
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disc edema and diffuse macular edema which may lead to massive macular 
edema.  
  Macular edema, glaucoma, cataracts and corneal diseases must be 
considered in diabetics facing blindness. Preservation of vision correlates 
well with blood pressure control and that patients with end stage renal 
disease suffering from diabetes now enjoy an equivalent visual prognosis 
whether treated by dialysis or undergo renal transplantation. It is important 
to consider laser photocoagulation for proliferative or pre-proliferative 
diabetic patients facing renal failure.  
  Since the progression of diabetic retinopathy is independent of 
diabetic nephropathy and not reversed by treatment of nephropathy, further 
follow up and treatment of diabetic retinopathy is imperative. In the past 
visual prognosis in dialysed diabetics was extremely poor(according to 
Shapero and County 1980), beginning dialysis between 1966 and 1971 had 
twenty nine percent risk of becoming blind and vision was lost in forty one 
percent in eyes at risk. These figures have improved in parallel with 
improvement in dialysis procedure and better control in blood pressure. 
Patients admitted between 1976 and 1979 had only one percent risk of 
amaurosis on dialysis. This observation invalidates past concerns that 
administration of heparin during dialysis adversely affects visual prognosis. 
Clear evidence documents that blindness in end stage renal disease is 
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avoidable. In addition, hypertension accelerates the evolution of background 
retinopathy to proliterative retinopathy. Treatment of hypertension and renal 
disease will decrease retinopathy particularly macular edema and stabilize 
vision.  
  Watnabe at all followed two hundred and sixty eight Japanese diabetic 
on haemodialysis who had fifty percent survival at six months with stable 
visual activity in three hundred and sixty four of four hundred and eighteen 
eyes 87.7% while twenty of the four hundred and eighteen eyes 8% 
deteoriated.  
ROLE OF PHOTOCOAGULATION   
  Diabetic end stage renal disease patients with persistent macular 
edema may benefit from macular photocoagulation. In diabetics with active 
proliferative retinopathy, pan retinal photocoagulation,22,27 may improve the 
visual prognosis by inducing involutional retinopathy and by removing 
vitreous hemorrhage and viteroretinal tractions. More over diabetes with end 
stage renal disease are predisposed to cataracts which may require surgical 
intervention. The progress made in improving the visual prognosis in 
diabetic end stage renal disease reflects the synergistic efforts made by 
physicians and ophthalmologists and emphasize the importance of team 
approach in preventing blindness.  
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DIABETIC RETINOPATHY AND RISK FACTORS  
  Approximately 10% of diabetic population has type I (Insulin 
dependent) diabetes mellitus which is usually diagnosed before the age of 
forty years.31 The majority of diabetic patients, however have a type II (non 
insulin dependent) diabetes mellitus which is usually diagnosed at the age of 
forty years. These patients may or may not be treated with insulin.  
  Although these patients with type I diabetes mellitus experience a high 
incidence of severe ocular complications and are more likely to have 
significant ocular problems during their life times, those with type II diabetes 
mellitus make up the majority of the clinical patients with the diabetic eye 
disease.  
RISK INDICATIONS OF RETINOPATHY   
JOINT CONTRACTURE  
      Association of retinopathy with contractures has been established. 
Eye examination in cases of joint contracture is needed.  
NEUROPATHY  
   Neuropathy in lower extremities may alter mobility in such a way that 
restoration maintenance of as much vision as possible is important. 
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Cardiovascular autonomic neuropathy is an independent risk factor for 
proliferative diabetic retinopathy.  
CONDITIONS THAT MAY AFFECT THE COURSE OF 
DIABETIC RETINOPATHY  
HYPERTENSION  
  Appropriate medical treatment is indicated for prevention of 
cardiovascular disease, stroke and death. Hypertension itself may result in 
hypertensive retinopathy super imposed on diabetic retinopathy.  
ELEVATED TRIGLYCERIDES  
  Appropriate management is important. Proper diet and reduced levels 
may result in less retinal vascular leakage.  
PROTEINURIA 
  Aggressive management of elevated creatnine in renal disease is 
indicated to avoid renal retinopathy which may increase the risk of 
progression of diabetic retinopathy.  
CARDIOVASCULAR DISEASE  
  Increased risk of cardiovascular disease particularly coronary vascular 
disease if often associated with an increased attenuation and atherosclerotic 
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closure of arterial system of retina.29 A decreased risk of hemorrhage into  
the vitreous may result but they may also be decrease in retinal function with 
an associated decrease in vision. Management of cardiovascular disease may 
help relieve some of the ischemic process in retina.  
CLINICAL TRIALS  
  There are no clinical trials that have specifically shown that control of 
systemic conditions that may affect the eyes, prevents the progression of 
diabetic retinopathy. Clinical experiences suggest an association with the 
systemic benefits of appropriate treatment of these problems.  
 Effect of haemodialysis on diabetic macular leakage. Tokuyama T, 
Ikeda T, Satok26 
Aim  
  To evaluate the effects of haemodialysis on macular oedema by 
flourescein angiography in patients with diabetic retinopathy and end stage 
renal disease.  
 
 
Results  
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  Flourescein angiograms obtained at 4 weeks showed that macular 
leakage was unchanged (70%), decreased in 10% and increased in 20% 
when compared with the basic line appearance.  
Conclusions 
  These results indicate that haemodialysis does not benefit macular 
leakage in diabetic patients receiving haemodialysis for end stage renal 
disease.  
 Renal pathology patterns in type II diabetes mellitus:relationship with 
retinopathy. The collaborative study group. (Schwartzmann, Lewis EJ, 
Leon, Martin T , Lewis JB, Battle D.) 
Background  
  The glomerular and retinal vessels and are both affected in patients 
with type I and type II diabetes mellitus. However, the prevalence of nodular 
form of diabetic glomerular sclerosis (Kimmelstiel/Wilson lesion) and other 
forms of glomerular pathology including diffuse mesangial sclerosis and 
their clinical correlates in type II are less well known.  
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Results   
  Patients with Kimmelestial Wilson nodules had more severe overall 
retinopathy than those with mesanglial sclerosis lesion. Six of seven with 
proliferative retinopathy had kimmelstiel Wilson nodules and seven without 
retinopathy had mesanglial sclerosis lesions.  
 A co-relation of the eye and kidney in diabetes mellitus and  
  hypertension. Yazdani I, Ahmed S, Channa A, Gayoori.  
 The study was undertaken to observe the co-relation between  
microangiopathic changes in diabetic retinopathy and microvascular 
changes in diabetic nephropathy. Included in the study were 64 
patients with chronic renal failure who were on maintenance dialysis, 
40had hypertension alone, 21 hypertension and diabetes and 3 had 
diabetes alone. On examination of retina, of 40 hypertensive patients, 
14 had positive findings, while in the hypertensive and diabetic and 
diabetic group, 20Patients out of 21, had positive findings. Nine 
patients in the hypertensive group had delayed chorodal filling on 
fluorescein angiography which was not very accurately reflected on 
funduscopy. In the diabetic and hypertensive group, 13patients having 
proteinuria of more than 1gm, also had exudates and haemorrhages in 
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the fundus. It was concluded that a correlation exists between the 
arterial changes in the fundus of the eye and the glomeruli of the 
kidney.  
 Clinical and epidemiological aspects of diabetic retinopathy and its  
  relationship with diabetic nephropathy.  
  Ergrafov Vlu, Mamaeva, Bishele NA, Luidina LI. Results of clinical 
and laboratory examinations of 161 diabetes are presented. The main factors 
or risk of nonproliferative diabetic retinopathy are the duration and degree of 
compensation of diabetes mellitus, development and stage of diabetic 
nephropathy, the latter factor replacing in experiments with simulation of 
diabetic retinopathy the level of arterial hypertension, and the blood serum 
content of high-density lipoprotein cholesterol and ration of total cholesterol 
to high- density lipoprotein cholesterol.  
 Discordance between retinopathy and nephropathy in type 2 diabetes 
KanauchiM, Kawano T, Uyamo H, Shiki H, Dohi K. 
  A total of 22 Patients with type 2 diabetes (139 males and 82 females) 
who consecutively underwent renal biopsy between 1982  and 1996 were 
investigated.  The severity of diffuse glomerular lesions was graded using 
the criteria a Gellman and coworkers, and diabetic retinopathy was classified 
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as absent, nonproliferative, or proliferative. The incidence of advanced 
nephropathy without retinopathy for all 22 cases with 2.3%.  
 Retinal complications in diabetics with renal failure DufierJL, Nguyen 
HV, Funck- Brentano JL  
 
  Study concluded on a series of 27 patients that all diabetics with end 
stage renal failure had retinopathy excepting one. Retinopathy, its severity 
and the prevalence of complications are primarily related to the evolution of 
diabetes, whatever the type and severity of the nephropathy. The aim of the 
study was to investigate the relationship between the grade of retinopathy 
and the severity of glomerular lesions in patients with type 2 diabetes. 
Results: only 5 patients of the 221 cases had no retinopathy. The rest of the 
cases either had absent, nonproliferative or proliferative retinopathy. The 
findings of this study were consistent with the hypothesis that there are 
important differences in some aspects of the pathogenesis or retinopathy and 
nephropathy.  
 Proliferating retinopathy in diabetes mellitus. Clinincal and autopsy 
results. Fishcher F.  
  Clinical and autopic investigations of thirty patients suffering from 
diabetes mellitus and retinopathia proliferans result in the findings that of the 
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various manifestations only retinopathy, nephropathy, and arterial 
hypertension are present in all cases, all other forms receding into the 
background. Conclusion : Diabetes mellitus in connection with retinopathia 
proliferans turns out to be the most serious form of the general diabetic 
disease.  
 Clinical profile of Indian non-insulin – dependent diabetics with 
nephropathy and renal failure. John L, Ganesh A, John G, Raju JM, 
Kirubakaran MG, Shastry JC.  
  Study conducted on 296 non-insulin depend and diabetic NIDDM 
Patients with nephropathy and renal failure. Results : Male preponderance 
was striking in this group and the age of onset of diabetes was between 30 
and 50 years in 75%. Retinopathy was present in 86% with proliferative 
changes in 20% and coronary artery disease in 40% of the people. It was 
observed that people with NDDM developing nephropathy and renal failure 
had early onset of the disease and are significantly more male.  
 Aggressive opthalmological management in diabetic end stage renal 
disease : A study of 31 consecutively referred patients: David H 
Berman, Eli A Friedman, Andrew P.Lurdin.  
  Prospective follow up of eye disease in patients with diabetic end 
stage nephropathy in referral unit of total 31 patients. Visual acuity and 
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diabetic retinopathy stabilized or improved in all 18eyes of the transplant 
patients and 41 of 44 eyes of the dialysis patients.  
 Visual status in Diabetic patients following: Therapy for end-stage 
nephropathy.  
  Robert C.Ramsay, M.D., Herbert L.Cantrill, M.D.William H, 
Knobloch, M.D., Christina M, Comty, M.D.,28 
  One hundred sixty five renal transplant recipients and 43 patients on 
dialysis therapy for diabetic nephropathy were followed in a prospective 
study of visual function.26 Visual acuity improved or remained stable in 74 
percent of the transplant group and 58percent of the dialysis group. For both 
groups, visual deteriotion increases with duration of follow up and is related 
to the presence of active retinopathy. Renal transplant is the treatment of 
choice for diabetic nephropathy with regard to maintenance of visual 
function.  
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PART –II 
MATERIALS AND METHODS 
PATIENTS AND METHODOLOGY  
   This is a prospective non randomized study of 50 patients who were 
diagnosed end stage renal disease of diabetic etiology with or without 
hypertension. The onset of end stage renal disease was restricted to be less 
than six months.  
 The following criteria were to be noted to fulfil the diagnosis of ESRD 
1. Raised BUN about 100mg/dl at time of diagnosis.  
2. Raised serum creatinine about 8mg/dl.  
3. Signs and symptoms of Uraemia for more than 3 months.  
4. Known diabetic for more than 5yrs with retinopathy.  
5. Only NIDDM patients were included.  
  Patients with underlying etiology other than diabetes and hypertension 
were rejected. Patients with concomitant eye disease were also rejected. 
Patients underwent regular hemodialysis of once a week. The type of dialysis 
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is bicarbonate and few patients underwent acetone dialysis. Where acidosis 
is present only bicarbonate dialysis is done.  
OPTHALMOLOGICAL EXAMINATION   
  Opthalmological examination is made twice and whenever the patient 
reports with diminished vision.  
Complete opthalmological evalution included  
 Best corrected visual acuity.  
 Slit lamp examination of both eyes.  
 Direct opthalmoscopy.  
 Fundus examination with 90D lens and slit lamp.  
 Fundus photographs and FFA in suspicion of neovascularization.  
 Diabetic retinopathy is classified as per ETDRS classification.  
 Hypertensive retinopathy classified as per Keith Wagner Barker 
classification.  
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Table 1  
OBSERVATION & ANALYSIS   
AGE  &  
SEX DISTRIBUTION  
     TOTAL  NO  OF  PATIENTS -  50  
Age No. of 
Patients – Male 
Percentage No.of 
Patients – Female 
Percentage 
55-60 16 32 14 28 
61-65 2 4 8 16 
66-75 4 8 6 12 
Total 22 44 28 56 
  Majority of the patients in this study were screened within 6 months of 
the start of symptoms of uremia patients were already under taking treatment 
for diabetes mellitus other with oral hypoglycaemic agents or insulin.  
  Majority of the patients were in the age group 55-60yrs, accounting to 
about 60%-men 32% & women 28%.  
  Most of the patients were women, accounting for 56% of the total.  
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SEX DISTRIBUTION 
No. of Patients – Male
No.of Patients – Female
Percentage
 
AGE DISTRIBUTION 
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FUNDUS PICTURE OF JEYARAMAN – 55/ M – CASE- 1 
(MODNPDR + CSME) 
 
 
FUNDUS PICTURE OF CHINNASAMY – 57/ M – CASE- 4 
(MODNPDR + GRADE 1 HTR CHANGES ) 
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TABLE  2 
DURATION OF DIABETES MELLITUS 
 IN RELATION TO ESRD 
TOTAL NO OF PATIENTS -50  
Duration of DM 
(Years) 
No. of Patients 
5-10 6 
11-15 28 
16-20 14 
>20 2 
 
Only NIDDM patients were taken in the study  
All patients were known to be diabetic for more than five years.  
Patients who were diabetic of about 11-15 years accounted for the majority.  
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Table 3 
SEVERITY OF DIABETIC RETINOPATHY  
AT BASELINE 
    TOTAL NO OF EYES = 100  
Severity of Diabetic 
Retinopathy 
No.of eyes  % 
Mild NPDR 0 0 
Moderate NPDR 8 8 
Severe NPDR 44 44 
Very Severe NPDR 24 24 
Early PDR 18 18 
High Risk PDR 6 6 
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SEVEIORITY OF RETINOPATHY 1 
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Very Severe NPDR
Early PDR
High Risk PDR
 
All patients of NIDDM with ESRD had retinopathy.    
Diabetic Retinopathy is graded under ETDRS classification.  
Non proliferative retinopathy in the form of severe retinopathy is the 
commonest retinopathy.  
The distribution was mild NPDR ‘0’, moderate NPDR in 8% severe NPDR 
44% , very severe NPDR 24%, early PDR 18%  and high risk PDR 6%.  
All patients underwent opthalmological examination with in one year of 
HAEMODIALYSIS and this was taken as base line retinopathy.  
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FUNDUS PICTURE OF LAKSHMANAN – 56/ M – CASE- 6 
(SNPDR + GRADE 1 HTR CHANGES ) 
 
FUNDUS PICTURE OF RAMESH – 59/ M – CASE- 9 
(SNPDR + CSME ) 
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BASE LINE RETINOPATHY 
FOLLOWUP RETINOPATHY 
TABLE -4 
SEVERITY OF DIABETIC RETINOPATHY  
AT FOLLOW UP : 
     TOTAL NO OF EYES :100  
Severity of Diabetic Retinopathy No.of eyes % 
Mild NPDR 0 0 
Moderate NPDR 8 8 
Severe NPDR 40 40 
Very Severe NPDR 28 28 
Early PDR 18 18 
High Risk PDR 6 6 
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Follow up examination of retinopathy was done at the end of 6 months and 
one year. 
Majority of the eyes was found to be stable at the end of  6months and one 
year.  
4 eyes with severe NPDR had progressed to very severe NPDR.  
No new vitreous haemorrhage, or retinal detachment was noticed.  
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Table 5 
CLINICALLY SIGNIFICANT MACULAR EDEMA IN 
DIALYSED ESRD AT BASELINE 
TOTAL NO OF EYES : 100  
Severity of diabetic Retinopathy No : Eyes Percentage 
Mild NPDR 0 0 
Moderate NPDR 2 2 
Severe NPDR 16 16 
Very severe NPDR 6 6 
Early PDR 7 7 
High Risk PDR 0 0 
Total 31 31% 
CSME was noticed in 31eyes of the total.  
Eyes with severe NPDR which accounted for majority also had the majority 
of CSME.  
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FUNDUS PICTURE OF VEILVENDAN -62 /F – CASE- 33 
(VSNPDR ) 
 
 
FUNDUS PICTURE OF PANDI– 66/ M – CASE- 41 
(EPDR + CSME) 
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TABLE 6 
CLINICALLY SIGNIFICANT MACULAR EDEMA IN 
DIALYSED DIABETIC ESRD AT FOLLOWUP  
TOTAL NO. OF EYES = 100  
Moderate CSME No. of eyes % 
Mild NPDR 0 0 
Moderate NPDR 2 2 
Severe NPDR 20 20 
Very severe NPDR 8 8 
Early PDR 8 8 
High Risk PDR 0 0 
Total 38 38 % 
7 new eyes at the end of the study developed CSME  
No evidence of hole or cystoids changes occurred  
15 eyes underwent argon laser photocoagulation and showed regression of 
edema.  
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TABLE 7 
HYPERTENSION IN DIABETIC ESRD ON DIALYSIS  
TOTAL NO. OF PATIENTS = 50  
Age No. of Patients % 
55- 60 8 16 
61- 65 8 16 
66- 70 4 8 
    
   Hypertension was presenting 40% of the study group -20 patients.  
   Age distribution showed 55 -60yrs group had 8 people, 61 -65 yrs group 
had 8 patients and 66-70 yrs group had 4 patients.  
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TABLE  8 
INCIDIENCE OF HYPERTENSION RETINOPATHY 
TOTAL NO. OF EYES = 100  
 No. of Eyes % 
Grade I 8 8 
Grade II 8 8 
Grade III 4 4 
Grade IV 0 0 
 
Combined retinopathy was present in 20 Patients of the total.  
Grade I & Grade II were the majority.  
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FUNDUS PICTURE OF KAMAYE –67/F – CASE- 47 
(HPDR) 
 
 
FUNDUS PICTURE OF KAMATCHI –68/F – CASE- 50 
(HPDR) 
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TABLE 9 
VISUAL ACUITY IN DIABETIC ESRD ON DIALYSIS  
    TOTAL NO OF EYES = 100   
BCVA Base line Follow up  
6/6 0 0 
6/9 4 2 
6/12 12 17 
6/18 12 13 
6/24 20 24 
6/36 36 27 
1/60 – 6/60 10 11 
CfCf – HM 2 2 
PL +_ PR 2 2 
No PL 2 2 
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  Visual acuity of no PL in two eyes was due to the presence of 
tractional retinal detachment majority of the visual acuity remained stable at 
the end of 6months. Few eyes showed progression of cataract.  
  Drop in visual acuity in three eyes was due to hard exudates near the 
macula.  
  15 eyes that underwent photocoagulation were found to improve in 
visual acuity of 1-2 line.  
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PAN RETINAL PHOTO COAGULATION OF KAMATCHI CASE- 50 
 
 
 
 
 
 
 
 
 
65 
 
DISCUSSION 
  This study was a nonrandomized prospective study including 50 
patients with ESRD on dialysis of Diabetes mellitus origin conducted in a 
tertiary hospital in South India. Patients were referred from the department 
of nephrology for detailed opthalmological checkup. Renal failure was 
diagnosed with the criteria mentioned in patients and methodology. All 
patients underwent routine haemodialysis. Most of the patients due to 
reasons of inability to come for the ideal 3week schedule underwent 1 week 
dialysis schedule. No difference is tried to be made with respect to whether 
acetone or bicarbonate dialysis was done.  
AGE DISTRIBUTION  
  The majority of the patients in the study were in the age group 55-
60years accounting for about 60% of the total. In the study conducted by 
John et al (1989) it was found that patients developing nephropathy and renal 
failure with underlying NIDDM  had early onset of disease between 30 and 
50 years accounting for almost 75%. Brenner et al found age distribution of 
ESRD patients of diabetic origin to be higher at 56 years. Robert C 
Ramsamy et al group of patients on an average were 48 years but this study 
group included both type I type II DM.  
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SEX DISTRIBUTION  
   Males and females were studied for their distribution in relation to 
retinopathy and nephropathy. It was found that ESRD of diabetic origin 
showed a slight female preponderance accounting for about 56%. John et al 
in the  Indian study at CMC, Vellore showed a striking male preponderance 
especially with early nephropathy. As nephropathy proceeds renal failure it 
was not possible to conclude if males were effected earlier in this study.  
  In the study conducted by Berman et al similar results were noted with 
females undergoing dialysis in upto 68% of the total. Robert C. Ramsamy et 
al showed almost equal distribution of males and females in their study. 
Three suppositions were given by Avram et al to explain why there are more 
women among the dialysed diabetic studied (1) women with diabetes 
mellitus live longer with the disease than men do. (2) women with diabetes 
may be more metabolically stable (3) More women are willing to accept 
dialysis and endure stress than are men.  
CLASSIFICATION  
   Diabetic Retinopathy was graded under the ETDRS classification 
with hypertensive retinopathy graded under keith wagner Barker 
Classification. Berman et al followed a classification that combined both 
Kanski and ETDR classification. The retinopathy was classified as no 
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Retinopathy, background retinopathy macular edema, nonproliferative 
retinopathy + macular edema, proliferative retinopathy, vitreous hemorrhage 
and tractional retinal detachment. More simpler classification have also been 
followed like in the Jean-Louis Brenato Fenck study mentioned in Diabetic 
Renal – retinal syndrome as early, edematous, mixed, ischemic and 
complicated. People with hypertension were classified in 4 groups as 
common arteriosclerosis, cross sign, exudates and papilledema.  
RETINOPATHY AND NEPHROPATHY 
   Frequency of retinopathy and nephropathy is explained in the 
WESDR study. An increasing frequency of retinopathy was found with 
increasing duration of diabetes. Prevalence rose sharply from 13.61% in 
those with diabetes of less than 5 years to 95.3%. In those with diabetes 
hypertension are present in all cases with significant proportion of people 
dying of uremia when there is associated underlying proliferative 
retinopathy.  
  In the Indian Study John et al (1989) it was found that out of 86% of 
people with diabetic retinopathy 20% of the people had proliferative 
changes. Whereas in this study the distribution of retinopathy was mild 
NPDR 0% moderate NPDR 8%, Severe NPDR 44% , very severe NPDR 
24% early PDR 18% and high risk PDR 6%. This study was concordant with 
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Bermal et al which showed a high percentage of background retinopathy and 
non-proliferative retinopathy in their study in the range of 52%.  
  Robert C Ramsamy et al in the study conducted on insulin dependent 
diabetes ESRD patients found proliferative diabetic retinopathy to be 
common at 59% at the outset of dialysis. Studies conducted by Engrafov et 
al showed that main risk factor or risk of non proliferative retinopathy are 
the duration and degree of compensation of diabetes mellitus and stage of 
diabetic nephropathy. In this study the underlying nephropathy is severe 
needing medical and renal replacement therapy hence  the presence of very 
severe, severe and proliferative retinopathy being common. To increase the 
specificity of renal insult and retinopathy Schwartz et al showed histological 
evidence of Kimmelstiel Wilson nodules and sever retinopathy. No renal 
biopsy was however done in any of our cases.  
HYPERTENSION  
   Incidence of hypertension and associated retinoapathy was 40% in 
our group of study. Epidemological studies mention hypertension as a risk 
factor for the development of diabetic retinopathy and may be superimposed 
on diabetic retinopathy.  
  Yazdani et al study showed out of 64 patients with CRF, 21 had 
Diabetes and hypertension accounting to about 32%. In this study, most 
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common retinopathy graded was group 1& 2 of Keith wagner Barker 
classification. Hypertension could be the underlying risk factor for the 
development of severe retinopathy.  
CSME  
  Clinically significant macular edema was noted in a significant 
proportion of patients at the out set of dialysis. It was noted to be 31%. The 
main visual morbidity in diabetes mellitus is CSME. The WESDR study 
noted significant also associations of proteinuria and macular edema was the 
commonest cause of visual morbidity in the Brener et al study.  
VISUAL ACUITY  
   Robert C.Ramsay et al in their study conformed the stabilization of 
baseline visual acuity in a majority and deteroriation in some. Patients on 
dialysis in this study by Robert C.Ramsamy were both Type I and Type 
11DM and followed for a minimum of 2 years on dialysis. As are study had 
a short follow up the end result could not be compared though similar causes 
of visual loss were found to be proliferative retinopathy and macular edema. 
Moreover where type 1 DM is associated with greater incidence of 
proliferative retinopathy on long term the same does not hold good for Type 
11DM who formed the major in this study group.  
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  Berman et al noted 7eyes in background retinopathy and 8eyes of non 
proliferative retinopathy to have macular edema. Both these groups 
constituted a majority of the total retinopathy. Prompt treatment in  the form 
of focal, panretinal photocoagulation or both resulted in stabilization of 
vision. Whereas in out study photocoagulation was not included.  
  Deterioration in visual acuity in our study demonstrated coincident 
with CSME and in some to the appearance of hard exudates on macula. 
Kline et al has suggested that type II DM is a group prone to macular edema. 
Baseline visual acuity was noted to be stabilized in a majority but this was 
just a I year follow up which needs to be further followed up for long time.  
  15eyes underwent photocoagulation for macular edema and showed 
improvement at the end of six months in the form of improved visual activity 
of 1-2 lines.  
  Other patients with clinically significant macular edema were advised 
to undergo photocoagulation.  
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SUMMARY 
  End stage renal disease is a microvascular insult of diabetes where 
retinopathy is also common. In this study of 50patients all end stage renal 
disease patients had retinopathy as it was one of the inclusion criteria. 
Common retinopathy seen was severe, very severe NPDR and PDR.  
  All patients had NIDDM, in whom renal failure occurs after 5 years of 
the duration of the disease. Nephropathy is more common among IDDM but 
as the number of NDDM far exceeds the number of IDDM hence  the total 
number of patients with ESRD is also greater. In India 5% of the diabetic 
population die of end stage renal disease.  
  Hypertension was seen in 40% of the study population. Whether it is 
the primary pathology or secondary result of ESRD is not known. 
Hypertension is by itself known to be associated with progression of non 
proliferative to proliferative retinopathy macular edema and retinopathy 
stabilization need good control of hypertension.  
  Majority of the patients were in the age group 55-60yrs with women 
accounting for the majority. Indian studies by John et al have showed earlier 
onset of nephropathy. The most common retinopathy seen was severe 44% 
and very severe NPDR 24%.  
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  Progression of retinopathy was seen in minority of 4 eyes at the six 
months.  
  Macular edema was seen in 31 eyes at the onset of dialysis. Seven new 
eyes developed macular edema at the end of six month follow up.  
  Macular edema is a pathology that needs prompt treatment. 15% eyes 
that underwent photocoagulation showed 1-2 line improvement.  
  Better understanding of importance of control of hypertension, 
improvement in hemodynamic monitoring, increased accessibility of dialysis 
units have improved the quality of life of people on dialysis and provide an 
opportunity for timely opthalmological intervention.  
  With majority of the studies having shown raised blood pressure poor 
glycaemic control and renal insufficiency as association of severe 
retinopathy, treatment with prompt opthalmogical intervention in the form of 
photocoagulation or vitrectomy decrease the visual impairment.  
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CONCLUSION  
 End stage renal disease of NIDDM is always associated with 
retinopathy as both are microvascular damage of the same disease of 
the same disease process.  
 Severe NPDR is the most common retinopathy.  
 Hypertension occurs in 40% of ESRD patients of NIDDM.  
 Combined retinopathy accounts for about 40% of the retinopathy.  
 Patients between 55-60yrs who are known to be diabetic are 
commonly associated with ESRD and retinopathy.  
 ESRD is found to be commonly associated with females.  
 Macular edema is seen in 31% of the patients with retinopathy.  
 Macular edema stabilizes with control of hypertension and dialysis.  
 New eyes without macular edema could however also develop 
macular edema during hemodialysis.  
 Diabetic retinopathy stabilizes on a short term basis in people with 
ESRD on dialysis.  
 Few eyes could progress in retinopathy when even on dialysis.  
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 Macular edema accounts for a subset of visual morbidity.  
 Prompt treatment in the form of photocoagulation and vitrectomy is 
utomost importance to reduce the visual impairment and improve 
quality of life.  
 It is also important for patients with diabetic ESRD to undergo 
opthalmological evaluation regularly.  
 Conditions that may affect the course of diabetic retinopathy like 
hypertension, elevated triglycerides, protein urea & cardiovascular 
disease should be look for and kept under control.  
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PROFORMA  
Name      Age     Sex   
Mrd.No. 
Diagnosis     
History of Diabetes Mellitus     -  Duration   
Hypertension       -   Duration   
Renal Parameters       BUN  
         Creatinine  
Treatment History  
Haemodialysis       Frequency  
         Type of Dialysis    
     Duration 
Ophthalmological evaluation.    RE    LE   
      Best corrected visual acuity.  
      Anterior segment evaluation.  
       Lids  
       EOM  
       Pupil  
       Lens  
       Slit lamp biomicroscopy with 90D  
       Fundus Direct Opthalmoscopy  
       Fundus Indirect Opthalmoscopy  
     Fundus photographs  
     Fundus flourescein angiography  
     Grading of retinopathy  
Follow up  Repetition of above six months and one year. 
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MASTER CHART 
S. 
NO Name Age Sex OP.No 
H/o 
DM 
Yrs 
H/o 
DM
Yrs 
V/A"0" 
Months Retinopathy "0" Months
V/A"0" 
Months Retinopathy "6" Months
RE LE RE LE RE LE RE LE 
1 Jeyaraman 55 
M 
470121 7   6/9 6/9 
Mod 
NPDR+ 
CSME 
Mod NPDR 
 + CSME 6/9 6/18 
Mod NPDR+ 
CSME 
Mod NPDR 
 + CSME 
2 Muthuraman 55 
M 
471341 8 7 6/12 6/12 
Mod 
NPDR+ 
CSME+ 
GrIHTR 
Mod NPDR+ 
CSME+ 
GrIHTR 
6/9 6/18 
Mod NPDR+ 
CSME+ 
GrIHTR 
Mod NPDR+
CSME+ 
GrIHTR 
3 Lakshmanan 56 
M
471432 12 8 6/12 6/12 
Mod 
NPDR+ 
GrIHTR 
Mod NPDR+ 
GrIHTR 6/12 6/12 
Mod NPDR+ 
GrIHTR 
Mod NPDR+
GrIHTR 
4 Chinnaswamy 57 
M 
471741 13 10 6/12 6/12 
Mod 
NPDR+ 
GrIHTR 
Mod NPDR+ 
GrIHTR 6/12 6/12 
Mod NPDR+ 
GrIHTR 
Mod NPDR+
GrIHTR 
5 Jegan 57 
M 
471934 11 8 6/12 6/12 SNPDR+ GrIHTR 
SNPDR+ 
GrIHTR 6/12 6/12 
SNPDR+ 
GrIHTR 
SNPDR+ 
GrIHTR 
6 Lakshmanan 56 
M 
482130 12 10 6/12 6/12 SNPDR+ GrIHTR 
SNPDR+ 
GrIHTR 6/12 6/12 
SNPDR+ 
GrIHTR 
SNPDR+ 
GrIHTR 
7 Rajesh 58 
M
482242 9 6 6/12 6/12 
SNPDR+ 
CSME- 
GrIHTR 
SNPDR+ 
CSME+ 
GrIHTR 
6/12 6/12 
SNPDR+ 
CSME+ 
GrIHTR 
SNPDR+ 
CSME+ 
GrIHTR 
8 Ramaiah 59 
M
482450 8 7 6/12 6/12 
SNPDR+ 
CSME+ 
GrIHTR 
SNPDR+ 
CSME+ 
GrIHTR 
6/12 6/12 
SNPDR+ 
CSME+ 
GrIHTR 
SNPDR+ 
CSME+ 
GrIHTR 
9 Ramesh 59 
M 
482452 11 5 6/36 6/36 SNPDR+ CSME 
SNPDR+ 
CSME 6/12 6/12 
SNPDR+ 
CSME 
SNPDR+ 
CSME 
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10 Suresh 59 
M 
484350 11   6/36 6/36 SNPDR+ CSME 
SNPDR+ 
CSME 6/12 6/12 SNPDR 
SNPDR+ 
CSME 
11 Selvaraj 60 
M 
484431 10   6/36 6/36 SNPDR+ CSME 
SNPDR+ 
CSME 6/12 6/18 SNPDR 
SNPDR+ 
CSME 
12 Ganesh 60 
M 
484521 10   6/36 6/36 SNPDR+ CSME 
SNPDR+ 
CSME 6/18 6/18 SNPDR 
SNPDR+ 
CSME 
13 Vasan 60 
M 
484630 11   6/36 6/36 SNPDR+ CSME 
SNPDR+ 
CSME 6/18 6/18 
SNPDR+ 
CSME 
SNPDR+ 
CSME 
14 Pandian 60 
M
484680 11 9 6/36 6/36 SNPDR+ CSME 
SNPDR+ 
CSME 6/18 6/18 
SNPDR+ 
CSME 
SNPDR+ 
CSME 
15 Seetha 56 
F 
484757 12 9 6/24 6/24 SNPDR+ GrIHTR 
SNPDR+ 
GrIHTR 6/24 6/24 
SNPDR+ 
GrIHTR 
SNPDR+ 
GrIHTR 
16 Ambika 57 
F 
484850 12 3 6/24 6/24 SNPDR+ GrIHTR 
SNPDR+ 
GrIHTR 6/24 6/24 
SNPDR+ 
GrIHTR 
SNPDR+ 
GrIHTR 
17 Alamelu 58 
F 
484900 13 4 6/24 6/24 SNPDR+ GrIHTR 
SNPDR+ 
GrIHTR 6/24 6/24 
SNPDR+ 
CSME+ 
GrIIHTR 
SNPDR+ 
CSME+ 
GrIIHTR 
18 Rajammal 58 
F 
484971 13 7 6/24 6/24 SNPDR+ GrIHTR 
SNPDR+ 
GrIHTR HM HM 
SNPDR+ 
CSME+ 
GrIIHTR 
SNPDR+ 
CSME+ 
GrIIHTR 
19 Sumathi 59 
F 
484980 12   6/24 6/24 SNPDR SNPDR 6/24 6/24 
SNPDR+ 
CSME+ 
GrIIHTR 
SNPDR+ 
CSME+ 
GrIIHTR 
20 Laksmi 58 
F 
490000 12   6/24 6/24 SNPDR SNPDR 6/24 6/24 SNPDR+ CSME SNPDR 
21 Muthu 59 M 491321 11   6/12 6/12 SNPDR SNPDR 6/18 6/18 SNPDR SNPDR 
22 Somu 59 M 491334 11   6/12 6/12 SNPDR SNPDR 6/18 6/18 SNPDR SNPDR 
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23 Veeralakshmi 58 F 494231 12   6/24 6/24 SNPDR SNPDR 6/24 6/24 SNPDR SNPDR 
24 Karpagam 57 F 494421 12   6/24 6/24 SNPDR SNPDR 6/24 6/24 SNPDR SNPDR 
25 Kumari 60 F 494700 15   6/36 6/36 SNPDR SNPDR 6/36 6/36 SNPDR SNPDR 
26 Velammal 59 F 495200 15   6/36 6/36 SNPDR SNPDR 6/36 6/36 SNPDR SNPDR 
27 Radhika 55 
F 
496111 14   6/36 6/36 VSNPDR+ CSME VSNPDR 6/36 6/36 VSNPDR VSNPDR 
28 Sundari 57 
F 
  13   6/36 6/36 VSNPDR+ CSME VSNPDR 6/36 6/36 VSNPDR VSNPDR 
29 Kathayee 56 F 496321 12   6/36 6/36 VSNPDR VSNPDR 6/36 6/36 VSNPDR VSNPDR 
30 Ramaselvi 56 F 496421 12   6/36 6/36 VSNPDR VSNPDR 6/36 6/60 VSNPDR VSNPDR 
31 Keerthi 62 
M 
496520 12 8 6/36 6/36 
VSNPDR+ 
CSME 
 GrIIHTR 
VSNPDR+ 
CSME 
 GrIIHTR 
6/36 6/60 VSNPDR+ GrIIHTR 
VSNPDR+ 
GrIIHTR 
32 Kumaran 63 
M 
497324 12 7 6/18 6/18 
VSNPDR+ 
CSME 
 GrIIHTR 
VSNPDR+ 
CSME 
 GrIIHTR 
6/36 5/60 VSNPDR+ GrIIHTR 
VSNPDR+ 
GrIIHTR 
33 Veilvandan 62 F 497338 12   6/18 6/18 VSNPDR VSNPDR 2/60 6/18 VSNPDR VSNPDR 
34 Kannammal 62 F 497426 12   6/18 6/18 VSNPDR VSNPDR 6/18 6/18 VSNPDR VSNPDR 
35 Laksnmi 62 
F 
497440 16   6/18 6/18 VSNPDR+ GrIIHTR 
VSNPDR+ 
GrIIHTR 6/12 6/18 
VSNPDR+ 
GrIIHTR 
VSNPDR+ 
GrIIHTR 
36 Periammal 62 
F 
497523 16 6 6/36 6/36 VSNPDR+ GrIIHTR 
VSNPDR+ 
GrIIHTR 6/24 6/24 
VSNPDR+ 
GrIIHTR 
VSNPDR+ 
GrIIHTR 
37 Perumaye 65 
F 
497538 16 8 6/36 6/36 VSNPDR+ GrIIHTR 
VSNPDR+ 
GrIIHTR 6/36 5/60 
VSNPDR+ 
GrIIHTR 
VSNPDR+ 
GrIIHTR 
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38 Subbu 65 
F 
498420 16 5 6/36 6/36 VSNPDR+ GrIIHTR 
VSNPDR+ 
GrIIHTR 5/60 5/60 
VSNPDR+ 
GrIIHTR 
VSNPDR+ 
GrIIHTR 
39 Petchi 61 
F 
499804 17 3 6/36 6/36 EPDR+ GrIIHTR 
VSNPDR+ 
GrIIHTR 6/24 6/24 
EPDR+ 
GrIIHTR 
VSNPDR+ 
GrIIHTR 
40 Chandra 62 
F 
499916 17 6 6/36 6/36 EPDR+ CSME 
VSNPDR+ 
GrIIHTR 6/24 6/24 
EPDR+ 
CSME 
VSNPDR+ 
GrIIHTR 
41 Lakshmi 66 
M 
503424 17 8 6/36 6/36 EPDR+ CSME 
EPDR+ 
CSME 6/24 6/24 
EPDR+ 
CSME 
EPDR+ 
CSME 
42 Sundaram 67 
M 
513632 17 9 1/60 5/60 EPDR+ CSME 
EPDR+ 
CSME HM 5/60 
EPDR+ 
CSME 
EPDR+ 
CSME 
43 Veerasamy 67 
M 
513754 17 10 5/60 2/60 EPDR+ CSME 
EPDR+ 
CSME 5/60 HM 
EPDR+ 
CSME 
EPDR+ 
CSME 
44 Sundaram 67 M 516432 17 8 6/36 6/36 EPDR VSNPDR 6/36 6/36 EPDR VSNPDR 
45 Meenakshi 66 F 527436 17 8 1/60 3/60 HPDR EPDR 1/60 3/60 HPDR EPDR 
46 Raasathi 67 F 538327 16   1/60 3/60 HPDR EPDR 1/60 3/60 HPDR EPDR 
47 Kamaye 67 F 549438 16   2/60 Cfcf HPDR EPDR 2/60 Cfcf HPDR EPDR 
48 Saraswathi 67 F 553674 16   2/60 Cfcf HPDR HPDR 2/60 Cfcf HPDR HPDR 
49 Revathi 67 F 564384 20   Nopl Pl+Pr HPDR HPDR NOP1 Pl+Pr HPDR HPDR 
50 Kamatchi 68 F 583842 21   Pl+PR Nopl HPDR HPDR Pl+PR Nopl  HPDR HPDR 
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MASTER CHART KEY 
DM- Diabetes Mellitus HR - high risk 
PR - projection of ray of 
light 
HT-Hyper tension                   NPDR - non proliferatvie diabetic retinopathy HM - hand movement  
Yrs - Years         PDR - proiferative diabetic retinopathy 
RE-Right Eye           PL - perception of light 
LE- Left Eye           Mod - moderate 
V/A - Visual acuity           VS - very severe 
S- Severe  
    E - 
early 
